✦ LIBER ✦

Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

✍ Scribed by Atasoy, B. M.; Dane, F.; Alsan Cetin, I.; Ozgen, Z.; Ucuncu Kefeli, A.; Ibrahimov, R.; Turhal, N. S.; Abacioglu, U.; Turkeri, L.

Book ID: 120443005
Publisher: Springer Milan
Year: 2013
Tongue: Spanish
Weight: 209 KB
Volume: 16
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-013-1047-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent chemoradiotherapy with low do

Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer

✍ Ufuk Abacioglu; Perran F Yumuk; Hale Caglar; Meric Sengoz; Nazim S Turhal 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 253 KB

Bladder Preservation by Neoadjuvant Chem

Bladder Preservation by Neoadjuvant Chemotherapy followed by Concurrent Chemoradiotherapy with Gemcitabine in Muscle Invasive Bladder Cancer (MIBC)

✍ Anandadas, C.; Thompson, C.; Sanderson, B.; Lyons, J.; Stratford, J.; Logue, J.P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 78 KB

MP55-09 SELECTIVE BLADDER-SPARING PROTOC

MP55-09 SELECTIVE BLADDER-SPARING PROTOCOL CONSISTING OF INDUCTION LOW-DOSE CHEMORADIOTHERAPY AND CONSOLIDATIVE PARTIAL CYSTECTOMY IN MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH SYNCHRONOUS OR METACHRONOUS MULTIFOCALITY

✍ Kijima, Toshiki; Kihara, Kazunori; Nakanishi, Yasukazu; Yoshida, Soichiro; Ishio 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 219 KB

Selective bladder-sparing protocol consi

Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients

✍ Fumitaka Koga; Kazunori Kihara; Soichiro Yoshida; Minato Yokoyama; Kazutaka Sait 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

Conservative treatment in patients with

Conservative treatment in patients with muscle-invasive bladder cancer by transurethral resection, neoadjuvant chemotherapy with gemcitabine and cisplatin, and accelerated radiotherapy with concomitant boost plus concurrent cisplatin – assessment of response and toxicity.

✍ Jadwiga NOWAK-SADZIKOWSKA; Teresa KOWALSKA; Jerzy JAKUBOWICZ; Teresa SZPYTMA 📂 Article 📅 2008 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 198 KB

7171 Chemoradiotherapy with cisplatin (C

7171 Chemoradiotherapy with cisplatin (C) and gemcitabine (G) plus concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients – clinical outcome and long term follow-up in a monoinstitutional experience

✍ Caffo, O.; Fellin, G.; Graffer, U.; Mussari, S.; Arcuri, C.; Caldara, A.; Murgia 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB